Aaron Cravens
Works at
Founder, Board director
Sources: doi.org
Grants and prizes
R44, Development of enzymatic tools for rapid measurement of Advanced Glycation and Lipoxidation End Product-protein adducts, R44AG084351, 2023–2027, 10 Jul 2026
National Institute of General Medical Sciences
R43, An enzyme-based assay for the detection of carboxyethyl lysine-protein adducts, R43GM154502, 2024–2025, 1 Jul 2024
R43, Development of enzymatic tools for rapid measurement of Advanced Glycation End Product-protein adducts, R43AG084351, 2023–2024, 14 Aug 2023
Sources: reporter.nih.gov